Skip to content

13F-HR/A filed by Altium Capital Management LLC

Altium Capital Management LLC filed this 13F-HR/A for the quarter ended 2021-09-30, filed 2021-11-17, with 124 holding rows worth $381,251,000.

Accession
0001420506-21-001737
Filed
2021-11-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A holdings report, amendment of type restatement, 124 entries on the cover page, a total value of $381,251,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $381,251,000 with VALUE read as thousands by filing date, 13F file number 028-20820. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
POLISHED COM INC28252C117*W EXP 06/02/2026,886,600$11,569,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM1,788,789$10,983,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW185,000$9,988,000thousands by filing date
CTI BIOPHARMA CORP12648L601COM3,313,000$9,773,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM864,020$7,586,000thousands by filing date
LANTHEUS HLDGS INC516544103COM290,000$7,447,000thousands by filing date
XTANT MED HLDGS INC98420P308COM NEW6,254,458$6,942,000thousands by filing date
VERASTEM INC92337C104COM2,253,000$6,939,000thousands by filing date
CERUS CORP157085101COM1,100,000$6,699,000thousands by filing date
CURIS INC231269200COM829,000$6,491,000thousands by filing date
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK1,233,642$6,279,000thousands by filing date
IMMATICS N.VN44445109SHS478,987$6,227,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM346,000$6,131,000thousands by filing date
ARCUTIS BIOTHERAPEUTICS INC03969K108COM255,000$6,092,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock26,000$6,055,000thousands by filing date
NEVRO CORP64157F103COM51,000$5,935,000thousands by filing date
CHINOOK THERAPEUTICS INC16961L106COM465,000$5,933,000thousands by filing date
CAREDX INC14167L103COM90,000$5,703,000thousands by filing date
SYROS PHARMACEUTICALS INC87184Q107COM1,272,412$5,688,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock203,354$5,600,000thousands by filing date
OCULAR THERAPEUTIX INC67576A100COM556,000$5,560,000thousands by filing date
AVIDITY BIOSCIENCES INC COM05370A108Stock225,000$5,542,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM166,700$5,494,000thousands by filing dateput
KALEYRA INC483379103COMMON EQUITY484,592$5,335,000thousands by filing date
IVERIC BIO INC46583P102COM328,101$5,328,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock74,000$5,224,000thousands by filing date
MYRIAD GENETICS INC62855J104COM158,000$5,102,000thousands by filing date
NATERA INC COM632307104Stock45,500$5,071,000thousands by filing date
MEI PHARMA INC55279B202COM NEW1,828,066$5,045,000thousands by filing date
NOCTURNE ACQUISITION CORPG6580S114ORDINARY SHARES500,000$4,990,000thousands by filing date
KEROS THERAPEUTICS INC COM492327101Stock126,000$4,985,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM609,689$4,847,000thousands by filing date
CASTLE BIOSCIENCES INC14843C105COMMON STOCK72,500$4,821,000thousands by filing date
VAREX IMAGING CORP92214X106COMMON STOCK158,000$4,456,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO440,589$4,318,000thousands by filing date
X4 Pharmaceuticals, Inc.98420X103COM804,598$4,256,000thousands by filing date
AFFIMED N VN01045108COM665,000$4,110,000thousands by filing date
CRINETICS PHARMACEUTICALS INC COM22663K107Stock193,000$4,063,000thousands by filing date
ILLUMINA INC452327109COM10,000$4,056,000thousands by filing date
EUCRATES BIOMEDICAL ACQU CORG3141W106CMN400,000$3,912,000thousands by filing date
EYEPOINT INC COM NEW30233G209Stock370,551$3,861,000thousands by filing date
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS92,000$3,826,000thousands by filing date
ARCTURUS THERAPEUTICS HLDGS03969T109COM80,000$3,822,000thousands by filing date
BRIDGEBIO PHARMA INC10806X102COM79,000$3,703,000thousands by filing date
RENOVACOR INC75989E106COM388,845$3,519,000thousands by filing date
PROFOUND MED CORP74319B502COM NEW235,000$3,440,000thousands by filing date
ICAD INC44934S206COM NEW320,000$3,440,000thousands by filing date
TRAVERE THERAPEUTICS INC89422G107COM141,000$3,419,000thousands by filing date
MORPHIC HLDG INC61775R105COM60,000$3,398,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock216,000$3,300,000thousands by filing date
VERRICA PHARMACEUTICALS INC92511W108COM256,244$3,203,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock144,000$3,187,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM625,469$3,071,000thousands by filing date
TRACON PHARMACEUTICALS INC89237H209COM NEW785,341$3,039,000thousands by filing date
MEREO BIOPHARMA GROUP PLC589492107CMN1,250,000$3,025,000thousands by filing date
GLOBUS MED INC CL A379577208Stock38,500$2,950,000thousands by filing date
DOUBLEDOWN INTERACTIVE CO LT25862B109ADS160,000$2,818,000thousands by filing date
IGM BIOSCIENCES INC449585108COM42,473$2,793,000thousands by filing date
KORU MEDICAL SYSTEMS INC759910102COMMON STOCK954,055$2,719,000thousands by filing date
DYNE THERAPEUTICS INC COM26818M108Stock166,636$2,706,000thousands by filing date
FLUX PWR HLDGS INC344057302COM NEW521,972$2,652,000thousands by filing date
CELCUITY INC15102K100COM145,000$2,610,000thousands by filing date
MOONLAKE IMMUNOTHERAPEUTICSG4444C102COM250,000$2,488,000thousands by filing date
TURMERIC ACQUISITION CORPG9127T108CMN254,000$2,487,000thousands by filing date
GALERA THERAPEUTICS EQUICLASS EQUITY36338D108COMMON STOCK300,605$2,435,000thousands by filing date
PHASEBIO PHARMACEUTICALS INC717224109COM775,000$2,410,000thousands by filing date
CARDIFF ONCOLOGY INC14147L108COM348,888$2,324,000thousands by filing date
SARISSA CAPITAL ACQUISITN COG7823W102CMN225,000$2,219,000thousands by filing date
VIQ SOLUTIONS INC91825V400COM NEW704,687$2,086,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM108,000$2,064,000thousands by filing date
YUMANITY THERAPEUTICS INC98872L102COM196,000$2,023,000thousands by filing date
PARDES BIOSCIENCES INC COM30318F100Stock200,000$1,990,000thousands by filing date
HEALTHCOR CATALIO ACQU CORPG44125105CL A SHS200,000$1,980,000thousands by filing date
GIGINTERNATIONAL1 INC37518W106CMN200,000$1,974,000thousands by filing date
MOBIX LABS INC COM CL AG2058L103Stock200,000$1,970,000thousands by filing date
LAKESHORE ACQUISITION I CORPG53521103ORDINARY SHARES200,000$1,966,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM111,834$1,952,000thousands by filing date
JIYA ACQUISITION CORP47760M102CMN200,000$1,950,000thousands by filing date
ELOXX PHARMACEUTICALS INC29014R103COM1,118,000$1,822,000thousands by filing date
ONCORUS INC68236R103COM192,054$1,794,000thousands by filing date
LIFEMD INC53216B104COM288,700$1,793,000thousands by filing date
CHIMERIX INC COM16934W106Stock281,790$1,744,000thousands by filing date
VINCERX PHARMA INC92731L106COM NEW107,625$1,740,000thousands by filing date
HILLMAN SOLUTIONS CORP431636109COM142,000$1,694,000thousands by filing date
PORTAGE BIOTECH INCG7185A128COM75,000$1,524,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM197,500$1,319,000thousands by filing date
VIRPAX PHARMACEUTICALS INC928251107COM271,846$1,305,000thousands by filing date
FAT BRANDS INC30258N121*W EXP 07/16/202227,000$1,297,000thousands by filing date
TAILWIND ACQUISITION CORP87403Q102COM CL A128,414$1,256,000thousands by filing date
INSULET CORP COM45784P101Stock4,250$1,208,000thousands by filing date
ADICET BIO INC007002108COM142,289$1,116,000thousands by filing date
CITIC CAPITAL ACQUISITION COG21513109COM CL A111,200$1,109,000thousands by filing date
STRYVE FOODS INC863685103CLASS A COM200,000$1,070,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO125,000$1,046,000thousands by filing date
ACHIEVE LIFE SCIENCES INC004468500COMMON STOCK122,000$1,037,000thousands by filing date
MOTIVE CAPITAL CORPG6293A103SHS CL A102,099$1,011,000thousands by filing date
ARYA SCIENCES ACQUISITN CORPG31658100CLASS A ORD SHS100,000$1,005,000thousands by filing date
BCLS ACQUISITION CORPG0904B105CMN100,000$996,000thousands by filing date
FIRSTMARK HORIZON ACQUISITIO33765Y101CL A COM100,000$980,000thousands by filing date
OMEGA ALPHA SPACG6749V107CL A100,000$974,000thousands by filing date
Allena Pharmaceuticals, Inc.018119107COM1,067,886$963,000thousands by filing date
COLISEUM ACQUISITION CORPG2263T123COM85,000$846,000thousands by filing date
CEREVEL THERAPEUTICS HLDNG I15678U128COM20,700$611,000thousands by filing dateput
ALIGOS THERAPEUTICS INC COM NEW01626L105Stock33,492$519,000thousands by filing date
TCR2 THERAPEUTICS INC87808K106COM59,150$503,000thousands by filing date
Renovacor Inc75989E114Warrant731,561$501,000thousands by filing date
COLOMBIER ACQUISITION CORP19533H108COM50,000$484,000thousands by filing date
IMMATICS N.VN44445117*W EXP 07/01/20297,467$389,000thousands by filing date
SCYNEXIS INC811292200COM NEW70,000$371,000thousands by filing date
HARBOR CUSTOM DEVELOPMENT IN41150T116*W EXP 05/09/202600,000$351,000thousands by filing date
KRYSTAL BIOTECH INC COM501147102Stock5,800$303,000thousands by filing datecall
POSEIDA THERAPEUTICS INC73730P108COM32,238$235,000thousands by filing date
NOCTURNE ACQUISITION CORPG6580S106RIGHT 12/26/2025500,000$210,000thousands by filing date
EUCRATES BIOMEDICAL ACQU CORG3141W122*W EXP 10/23/202133,333$107,000thousands by filing date
Reservoir Media Inc W Exp 08/26/20276119X113SPAC Combination50,000$99,000thousands by filing date
HEALTH SCIENCES ACQ CORP 2G4411D109ORD SHS10,000$99,000thousands by filing date
SURROZEN INC86889P117*W EXP 08/01/20382,233$94,000thousands by filing date
LAKESHORE ACQUISITION I CORPG53521111*W EXP 07/15/202150,000$79,000thousands by filing date
SARISSA CAPITAL ACQUISITN COG7823W110*W EXP 10/23/20275,000$75,000thousands by filing date
CHAVANT CAPITAL ACQUISITN COG2058L111*W EXP 99/99/999150,000$72,000thousands by filing date
TURMERIC ACQUISITION CORPG9127T124WTS84,666$55,000thousands by filing date
GIGINTERNATIONAL1 INC37518W114*W EXP 04/19/20250,000$37,000thousands by filing date
COLOMBIER ACQUISITION CORP19533H116*W EXP 99/99/99916,666$9,000thousands by filing date
UPHEALTH INC 11.5000EXP07/01/202491532B119WARR10,000$5,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-21-001713 superseded2021-11-15acceptance time not in the bulk data set
13F-HR/A 0001420506-21-001737this filing2021-11-17acceptance time not in the bulk data set